Healthcare Professionals

Committed to helping you meet the evolving challenges and opportunities in patient care.

Healthcare Professionals
  • Critical Care

    Providing innovative therapies and technologies to help you treat patients with life-threatening illnesses in the ICU.

  • Hospital Care

    From the pharmacy to the bedside, we help you maximize safety, streamline processes and build cost efficiency throughout the hospital.

  • Nutritional Care

    Acute and chronic nutritional care for your patients who are unable to get adequate nutrients orally or enterally.

  • Renal Care

    Pioneering innovation in hemodialysis and peritoneal dialysis to help you achieve better outcomes for your patients.

  • Surgical Care

    Delivering innovative surgical products that help you operate with confidence, precision and speed.

  • Our Products

    Our portfolio of acute, nutritional, renal, hospital and surgical care products helps advance healthcare around the world.

Perspectives

For more than 85-years, we have worked at the intersection of saving and sustaining lives.

Perspectives

Our Story

Our more than 85-year heritage gives us distinct perspective on the needs of patients and caregivers. We lead today by putting those insights to work to deliver new, better healthcare solutions and access to care in the communities where we live and work.

Our Story
  • Our Governance

    We are proud of our strong commitment to maintaining the highest standards of corporate governance.

  • Fueling Collaborative Innovation

    Nurturing a culture of innovation is critical to delivering on our mission to save and sustain lives. We partner with the healthcare community to continually find more efficient, smarter ways to help solve the world's most pressing healthcare challenges.

  • Corporate Responsibility

    We are committed to doing business the right way, ensuring that we champion our employees, our communities, our customers and patients, and our environment in everything we do.

  • Inclusion & Diversity

    We are committed to attracting, motivating and retaining an inclusive and diverse workforce.

  • Our History

    For more than 85 years, we’ve been focused on saving and sustaining lives and elevating patient care.

Patients

Helping you reach a healthy life, full of possibility.

Patients
  • Critical Care

    When every moment counts, our therapies help healthcare specialists provide life-sustaining treatment to you or your loved one.

  • Hospital Care

    From the pharmacy to the bedside, we support you and your healthcare providers with IV medications and infusion technologies designed with safety in mind.

  • Nutritional Care

    When medical conditions prevent you from adequately feeding yourself, we provide life-saving clinical nutrition options to help you regain or maintain your health.

  • Renal Care

    Chronic kidney disease (CKD) is an ongoing journey. While every journey is unique, Baxter is with you every step of the way, providing options to meet your lifestyle needs.

  • Surgical Care

    We partner with surgical teams around the world so they can operate with confidence, precision and speed for a successful outcome to your surgery.

Baxter to Present Significant Data at ERA-EDTA 2017 to Help Advance New Standards of Renal Care

Press Release

  • Baxter will present 17 abstracts on new in-center and home dialysis data

  • Baxter to sponsor three industry innovation symposia, presented by global leaders on HDx therapy, telehealth in home dialysis and acute therapy

PDF

Deerfield, Ill. -

Baxter International Inc. (NYSE: BAX), a global innovator in renal care, announced today that it will make significant contributions to the scientific exchange at the 54th Congress of the European Renal Association and European Dialysis and Transplant Association (ERA-EDTA), Madrid, June 3-6. Baxter will present 17 abstracts highlighting data aimed at improving end-stage renal disease (ESRD) patient care in both in-center hemodialysis (ICHD) and home peritoneal dialysis (PD).

“Baxter continues to advance renal therapies like HDx and telehealth technologies to help ESRD patients have access to new standards of dialysis care,” said Dheerendra Kommala, M.D., vice president, Medical Affairs, Baxter. “We are committed to robustly contributing to scientific exchange at important conferences like ERA-EDTA, in hopes of sharing our learnings and inspiring better outcomes for patients globally.”

Baxter data presentation highlights include:

In-Center Hemodialysis

  • Retention of Different Types of Pyrogens by Membranes of Different Pore Size: Abstract #SP488.
  • Does Increasing Membrane Pore Size Affect Endotoxin Permeability? A Novel Dialysis Simulation Set-Up: Abstract #MP537.
  • Lack Of Correlation Between Dialyzer Albumin Sieving Coefficients and In Vivo Albumin Removal In Hemodialysis and Hemodiafiltration: Abstract #MP522.

Peritoneal Dialysis and Telehealth

  • Impact of Remote Patient Management in Hospitals Conducting APD: Shifting the Nursing Care Paradigm: Abstract #SP508.
  • Hypokalemia in the Peritoneal Dialysis and Outcome Practice Patterns Study (PDOPPS): International Variability and Clinical Predictors: Abstract #SP498.
  • Discrepancy between Prescribed and Actual APD Prescription Delivery: Identification Using Cycler Remote Management Technology: Abstract #MP557.
  • Early Peritoneal Dialysis Attrition: Preliminary Results from the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS): Abstract #MO061.

In addition to Baxter’s data presentations, the company will host three industry symposia led by global therapy experts, and host a booth (#5,005) featuring recently launched ICHD and APD technologies.

Baxter-sponsored industry innovation symposia:

  • Advancing Renal Therapies through HDx (expanded hemodialysis): The international faculty will discuss the importance of efficient removal of large middle molecules, and the research indicating the potential role of those molecules in cardiovascular disease and inflammation risks for ICHD ESRD patients. Sunday, June 4; 13:45–14:45; Hall 10.
  • Long-term Dialysis Dependence after Acute Kidney Injury: The Health-Economic Impact The international speakers will discuss recent data showing the difference between initial use of intermittent renal replacement therapy (RRT) and the use of continuous RRT, including the economic implications of non-recovery from AKI and long-term dialysis dependence. Sunday, June 4; 18:45–19:45; Hall N107–108.
  • Remote Patient Management (RPM) in Home Dialysis: Changing the Paradigm of Care: The international faculty will discuss the applicability and current experience of RPM (telehealth) for the home PD population, and prospects for improved access and outcomes. Monday, June 5; 13:45–14:45; Hall N103–104.

HOMECHOICE CLARIA with SHARESOURCE is available in select European, Asian and Latin American countries. SHARESOURCE is available with the AMIA APD system in the United States and Canada. THERANOVA is available in select European and Asia Pacific countries: It is not yet available in the United States.

For prescription only. For safe and proper use of the devices mentioned herein, refer to the complete instructions in the Operator's Manual.

About Baxter

Baxter provides a broad portfolio of essential renal and hospital products, including home, acute and in-center dialysis; sterile IV solutions; infusion systems and devices; parenteral nutrition; surgery products and anesthetics; and pharmacy automation, software and services. The company’s global footprint and the critical nature of its products and services play a key role in expanding access to healthcare in emerging and developed countries. Baxter’s employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of healthcare innovations that enable patient care.

Baxter, Amia, HomeChoice Claria, Sharesource and Theranova are registered trademarks of Baxter International Inc.